Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 27, 2017
Insider Transaction Report
Form 4
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2017-01-25$3.87/sh−249$964→ 26,164 total
Footnotes (1)
- [F1]Includes 13,771 shares of unvested restricted stock.